The U.S. stock market has experienced a mix of volatility and optimism recently, with inflation readings easing concerns about potential interest rate hikes. Amidst these fluctuations, penny stocks remain an intriguing segment for investors seeking growth opportunities at lower price points. Although the term ‘penny stock’ might seem outdated, these smaller or newer companies can still offer significant potential when supported by strong financials and solid fundamentals.
|
Name |
Share Price |
Market Cap |
Financial Health Rating |
|
QuantaSing Group (NasdaqGM:QSG) |
$3.08 |
$125.74M |
★★★★★★ |
|
Safe Bulkers (NYSE:SB) |
$3.75 |
$409.62M |
★★★★☆☆ |
|
BAB (OTCPK:BABB) |
$0.87 |
$5.96M |
★★★★★☆ |
|
Golden Growers Cooperative (OTCPK:GGRO.U) |
$4.50 |
$67.38M |
★★★★★★ |
|
North European Oil Royalty Trust (NYSE:NRT) |
$4.49 |
$40.53M |
★★★★★★ |
|
Imperial Petroleum (NasdaqCM:IMPP) |
$2.51 |
$76.74M |
★★★★★★ |
|
Permianville Royalty Trust (NYSE:PVL) |
$1.46 |
$47.19M |
★★★★★★ |
|
PHX Minerals (NYSE:PHX) |
$4.20 |
$155.92M |
★★★★★☆ |
|
Smith Micro Software (NasdaqCM:SMSI) |
$1.37 |
$23.94M |
★★★★★☆ |
|
CBAK Energy Technology (NasdaqCM:CBAT) |
$0.8201 |
$75.14M |
★★★★★☆ |
Click here to see the full list of 748 stocks from our US Penny Stocks screener.
We’re going to check out a few of the best picks from our screener tool.
Simply Wall St Financial Health Rating: ★★★★★★
Overview: Connect Biopharma Holdings Limited is a clinical-stage biopharmaceutical company focused on developing therapies for T cell-driven inflammatory diseases, with a market cap of $46.69 million.
Operations: Connect Biopharma Holdings Limited has not reported any revenue segments.
Market Cap: $46.69M
Connect Biopharma Holdings, with a market cap of US$46.69 million, is a pre-revenue clinical-stage biopharmaceutical company focusing on T cell-driven inflammatory diseases. Although unprofitable, it has reduced losses by 21.1% annually over the past five years and boasts a strong cash position with short-term assets significantly exceeding liabilities. The company is debt-free and hasn’t diluted shareholders recently but faces high volatility in its share price. Recent changes include appointing CBIZ CPAs P.C. as auditors and leadership transitions with board resignations, indicating strategic shifts amidst efforts to stabilize operations and enhance growth prospects.
Simply Wall St Financial Health Rating: ★★★★☆☆
Overview: Duluth Holdings Inc. operates in the United States, offering casual wear, workwear, outdoor apparel, and accessories for men and women under the Duluth Trading brand with a market cap of $97.09 million.